Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study
These results indicate early and substantial improvements in patients' perception of their QoL and functioning with alemtuzumab that were sustained over three years.
Authors
- Elena Álvarez Rodríguez
- José Eustasio Meca Lallana (ORCID: https://orcid.org/0000-0001-5050-9890)
- Bonaventura Casanova (ORCID: https://orcid.org/0000-0003-3806-925X)
- Mireia Forner
- Baldo Toledo
- Antonio Pato Pato
- Sara Eichau
Institutions
- University Hospital Complex Of Vigo (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Hospital Universitario Virgen Macarena (ES)
- Sanofi (Spain) (ES)
- Povisa Hospital (ES)
- Hospital Universitario Virgen de la Arrixaca (ES)
- Universidad Católica de Murcia (ES)
Publication Details
- Journal
- Journal of Patient-Reported Outcomes
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s41687-024-00822-9
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Sanofi
- Sanofi España